Related Experiment Videos

Infantile autophagic vacuolar myopathy is distinct from Danon disease

A Yamamoto1, Y Morisawa, A Verloes

  • 1Department of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo, Japan.

Neurology
|September 12, 2001
PubMed

Insights

Danon disease, a lysosomal glycogen storage disorder, results from LAMP-2 deficiency. Infantile cases with similar features but present LAMP-2 protein are distinct and may resemble X-linked myopathy with excessive autophagy.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Danon disease is a rare genetic disorder caused by mutations in the lysosome-associated membrane protein-2 (LAMP-2) gene, leading to lysosomal dysfunction and glycogen accumulation.
  • It typically manifests in adolescence or adulthood, characterized by cardiomyopathy, intellectual disability, and skeletal myopathy.

Observation:

  • Two infantile patients presented with clinical and histological features mimicking Danon disease.
  • However, unlike classic Danon disease, LAMP-2 protein was present in the skeletal muscle of these infants.
  • One patient showed C5b-9 deposition and multilayered basal lamina, suggesting a different underlying pathology.

Findings:

  • The infantile disorder, despite overlapping features, is distinct from Danon disease due to the presence of LAMP-2 protein.
  • The observed pathological features in one infant suggest a potential link to X-linked myopathy with excessive autophagy.

Implications:

  • This distinction is crucial for accurate diagnosis and understanding the pathogenesis of infantile lysosomal storage disorders.
  • Further research is needed to elucidate the specific genetic and molecular mechanisms underlying this infantile myopathy.
  • Identifying distinct disease entities aids in developing targeted therapeutic strategies for glycogen storage diseases.

Related Concept Videos